Aileron Therapeutics's total assets for Q3 2024 were $104.22M, a decrease of -4.74% from the previous quarter. ALRN total liabilities were $8.98M for the fiscal quarter, a 7.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.